Gene Query: S100A10

Dataset Description Geneva Score
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 131.66
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 103.17
Chromatin-informed inference of transcriptional programs in gynecologic cancers 103.17
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 95.44
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 88.63
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 70.51
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 70.26
Expression by CD133+ cells isolated from the adult human exocrine pancreas 68.44
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 65.4
Mechanistic Model-Guided Study of Embryonic Morphogenesis 63.91
WRN knockout effects upon gene expression in SW48 and OVK18 61.73
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 60.78
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 60.78
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 60.75
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 59.41
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 59.33
RNA-seq analyses of human prostate cancer cells 56.53
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 56.37
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 55.97
NR2F2 study 55.97
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 55.44
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 54.13
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 52.16
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 51.84
Transcriptomic analysis of human tonsillar TFH subsets 51.18
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 50.69
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 50.65
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 49.89
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 48.75
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 48.05
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 46.85
Lipid degradation promotes prostate cancer cell survival 45.98
Peptidomimetic blockade of MYB in acute myeloid leukemia 45.65
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 45.65
Transcriptome profiling of Normal and Cancerous Prostate Cells 45.11
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 45.1
Global expression profiles in cardiac progenitor cells generated by ISX-9 45.1
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 43.77
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 43.77
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 43.12
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 43.0
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 42.15
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 41.81
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 41.1
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 40.38
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 39.62
The regulartory role of ZCCHC24 in splicing machinery 39.48
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 39.35
RNA-seq of young and quiescent MRC-5 human fibroblasts 38.78
Knockdown of ADNP in HCT116 colon cancer cells 38.57
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 38.54
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 38.35
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 37.6
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 37.6
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 37.23
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 36.85
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 36.43
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 35.78
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 35.78
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 34.23
MYCi975 regulates MYC target genes 33.99
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 33.89
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 33.81
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 33.45
BASP1 modifies the Tamoxifen response 33.35
DJ-1 is dispensable for human stem cell homeostasis 33.01
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 32.8
Induced DNA demethylation, genome instability and transcription 32.8
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 32.45
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 32.16
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 32.16
Spliceosomal disruption of the non-canonical BAF complex in cancer 32.08
The DPYSL2 gene connects mTOR and schizophrenia 31.96
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 31.77
A prostate cancer chromatin interaction map 31.72
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 31.71
BI Human Reference Epigenome Mapping Project 31.06
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 30.56
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 30.55
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 30.26
Transcriptomic and gene ontology profiling of the human corneal cell types 29.86
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 29.77
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 29.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 28.91
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 28.91
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 28.8
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 28.59
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 28.37
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 28.36
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 28.3
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 28.28
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 27.57
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 27.52
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 27.39
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 27.34
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 27.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 26.93
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 26.93
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 26.74
Patient-derived luminal breast cancer xenografts with progestins 26.74
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 26.74
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 26.65
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 26.08
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 25.96
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 25.86
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 25.65
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 25.54
Control of prostate tumour growth by the long non-coding RNA GHSROS 25.33
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 25.27
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 25.27
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 25.22
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 25.05
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 25.03
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 25.03
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 24.92
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 24.55
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 24.1
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 24.09
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 24.03
Differential analysis of gene regulation at transcript resolution by RNA-Seq 24.0
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 24.0
The effect of PPARG inhibition on human angiomyolipoma cells 23.9
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 23.77
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 23.49
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 23.45
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 23.28
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 23.25
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 23.11
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 23.04
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 23.02
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 22.98
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 22.91
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 22.69
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 22.64
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 22.52
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 22.43
Genome-wide chromatin analysis of Ewing sarcoma 22.41
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 22.41
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 22.23
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 22.23
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 22.18
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 22.18
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 22.09
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 21.98
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 21.69
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 21.62
Aneuploidy triggers an immune response 21.52
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 21.47
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 21.45
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 21.43
RNA-seq analysis of RALD iPSCs after in vitro differentiation 21.31
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 21.3
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 21.3
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 21.28
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 21.13
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 20.9
Endometrial transcriptome and PGR cistrome in cycling fertile women 20.85
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 20.85
MEIS1 regulates hematopoiesis in hPSCs 20.84
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 20.77
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 20.75
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 20.75
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 20.75
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 20.75
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 20.6
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 20.44
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 20.32
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.29
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 20.25
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 20.16
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 20.11
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 20.02
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 20.02
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 19.83
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 19.8
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 19.66
RNA-seq data from human lymphoma cell lines 19.55
ChIP-seq and RNA-seq from human lymphoma cell lines 19.55
Primary human trophoblast from term placenta 19.43
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 19.42
Gene expression profiling of human and murine in vitro muscle differentiation 19.37
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 19.35
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 19.28
ARS2 is a general suppressor of pervasive transcription [RNAseq] 19.12
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 19.11
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 19.11
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 19.02
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 18.82
Gene expression changes upon drug withdrawal (Mel888 cell line) 18.74
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 18.63
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 18.6
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 18.56
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 18.55
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 18.51
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 18.47
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 18.36
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 18.36
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 18.23
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 18.15
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 18.14
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 18.09
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 17.92
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 17.91
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 17.91
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 17.89
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 17.77
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 17.76
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 17.74
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 17.72
Gene expression analysis in response to hypoxic pathway inhibition 17.63
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 17.61
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 17.6
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 17.56
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 17.56
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 17.44
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 17.43
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 17.3
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 17.29
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 17.27
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 17.27
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 17.18
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 17.16
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 17.16
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 17.15
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 17.15
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 17.15
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 17.13
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 17.09
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.06
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 16.98
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 16.86
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 16.76
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 16.7
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 16.57
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 16.56
NKX2.2 16.56
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 16.55
Disruption of GRIN2B impairs differentiation in human neurons 16.54
naive T cell heterogeneity after neonatal thymectomy 16.53
Accurate annotation of human protein-coding small open reading frames 16.39
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 16.34
RNA-seq in HepG2 and IMR90 cells 16.32
Evolution of a transcriptional regulator from a transmembrane nucleoporin 16.32
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 16.25
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 16.21
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 16.2
EWS-Fli and LNC regulated genes in comparison to GFP samples 16.12
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 16.09
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 16.09
Nonpregnant and term pregnant human myometrial tissues 16.03
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 16.03
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 15.96
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 15.95
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 15.92
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 15.92
The human blood-nerve barrier transcriptome 15.89
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 15.81
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 15.75
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 15.75
RNA-seq analysis of control and Myc-induced U2OS cells 15.73
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 15.71
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 15.66
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 15.65
RNA m5C Methylation in breast cancer using MeRIP-Seq 15.5
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 15.38
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 15.38
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 15.38
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 15.38
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 15.27
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 15.27
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 15.2
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 15.16
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 15.03
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 14.99
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 14.94
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 14.93
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 14.84
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 14.8
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 14.72
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.64
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 14.63
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 14.62
RNA-seq of CD33 KO and control HSPCs 14.54
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 13.96
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 13.93
RNA-seq of stable and unstable section of human atherosclerotic plaques 13.91
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 13.87
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 13.87
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 13.79
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 13.79
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 13.73
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 13.72
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 13.72
CHD1 regulates cell fate determination by activation of differentiation-induced genes 13.6
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.46
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.39
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 13.39
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 13.39
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 13.34
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 13.26
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 13.23
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 13.22
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 13.22
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 13.21
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 13.12
RNA-seq of cancer cell lines treated with T-025 13.03
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 13.03
Biological effect of chronic mistranslation in mammalian cells 12.98
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 12.76
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 12.76
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 12.71
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 12.7
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 12.66
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 12.65
Expression profiling of etoposide-induced senescent cells 12.48
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 12.27
Effect of BMP inhibition or stimulation of primary human keratinocytes 12.25
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 12.25
RNA Sequencing of three pairs of gastric cancer 12.2
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 12.19
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 12.19
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 12.16
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 12.16
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 12.07
The Glioma-Infiltrating T Cell Receptor Repertoire 12.03
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 11.98
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 11.93
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 11.67
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 11.59
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 11.49
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 11.44
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 11.36
CDK4/6 inhibitor resistance in prostate cancer 11.36
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 11.18
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 11.1
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 11.07
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 11.06
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 10.97
Non-coding regions are the main source of tumor-specific antigens 10.92
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 10.68
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 10.63
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 10.5
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 10.29
Aging-associated patterns in the expression of human endogenous retroviruses 10.25
O-glcnAc reprograms cellular energetics 10.2
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 10.19
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 10.12
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 10.09
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 10.08
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 9.88
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 9.81
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 9.8
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 9.79
Targeting MTHFD2 in Acute Myeloid Leukemia 9.79
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 9.77
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 9.6
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 9.6
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 9.59
Expression profiling of MCF-7 cells with treatment of TCDD 9.42
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 9.42
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 9.34
Hepatocyte maturation 9.33
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 9.33
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 9.31
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 9.29
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.2
Transcriptome analysis of kidney organoids 8.94
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 8.83
Functional astrocytes differentiated from hiPSCs 8.78
Gene profiling of human adult and pediatric liver cancer cells 8.75
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 8.75
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 8.64
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 8.64
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 8.55
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 8.41
Redifferentiation of expanded human islet β cells by inhibition of ARX 8.35
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 8.34
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 8.29
Electronic cigarettes 8.05
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 7.9
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 7.79
Loss of endometrial plasticity in recurrent pregnancy loss 7.79
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 7.52
An optimization system for isolating and sequencing of single human colon cancer cells 7.48
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 7.43
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 7.06
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 7.02
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 6.96
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.87
6.82
ARID1A and ARID1B loss in HCT116 cells 6.8
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 6.67
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.6
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 6.4
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 6.33
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.32
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.12
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.12
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.08
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 6.06
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.0
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.98
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 5.92
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 5.83
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.61
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 5.55
Transcriptome analyses of human pancreatic islets and pseudoislets 5.54
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.53
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 5.45
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 5.38
Transcriptional dependencies in diffuse intrinsic pontine glioma 5.26
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 5.12
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 4.97
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 4.93
Leucegene: ALL sequencing 4.86
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 4.68
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.63
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.6
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 4.57
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.47
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 4.26
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 4.25
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.24
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 4.22
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.15
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 4.11
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.08
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 4.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.88
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.82
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.74
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.67
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.63
Unique features and clinical importance of acute alloreactive immune responses 3.55
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.47
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 3.43
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 3.41
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 3.39
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.39
Identification of long noncoding RNAs regulated by p53 3.32
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.11
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.11
Single-cell analysis of human kidney organoids 2.63
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.57
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.57
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.5
Engineering Patient-Specific Tissue Implants 2.46
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.44
RNA-sequencing of healthy human skeletal myocytes 2.44
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.25
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.25
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.25
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 2.2
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.16
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.12
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.11
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.0
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.99
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.99
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.98
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.96
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.92
Gene expression alterations of pancreatic intraepithlial neoplasia 1.92
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.89
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.89
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.81
Changes in human endometrial gland transcriptome over the window of implantation 1.79
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 1.79
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 1.79
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.75
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.62
Role of cervicovaginal microbiota in genital inflammation 1.53
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 1.43
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 1.43
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.38
FOXP2's impact on the primate transcriptome 1.28
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.88
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.7
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.64
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.61
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.54
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.37
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.34
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.32
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.32
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.19
miR941 overexpression experiment 0.18
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.18
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.14
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.14
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.14
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.13
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.11
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.09
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.08
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation